Imvax Penn 2
Pharma & Biotech company headquartered in Philadelphia, PA. Cross-border supply chain, facility locations, and freight intelligence below.
Imvax glioblastoma heat-shock protein-peptide complex vaccine developer; UNITE GBM trial.
- Industry
- Pharma & Biotech
- Headquarters
- Philadelphia, PA
- Employees
- 50
- Revenue
- revenue of $1.2M
- US facilities
- Philadelphia, PA
Start a free trial to see Imvax Penn 2’s full freight profile — facility network, cross-border lanes, and shipper intelligence.